A Phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer.
Hortobagyi
G N
GN
Department of Breast Medical Oncology, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Hung
M C
MC
Lopez-Berestein
G
G
D017500:Adenovirus E1A Proteins / Q000235:genetics*; D001943:Breast Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D002985:Clinical Protocols; D005260:Female; D015316:Genetic Therapy; D006801:Humans; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000235:genetics / Q000628:therapy*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*
D017500:Adenovirus E1A Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases